We encourage authors to provide detailed information within their submission to facilitate the interpretation and replication of experiments. Authors can upload supporting documentation to indicate the use of appropriate reporting guidelines for health-related
Sample-size estimation
 You should state whether an appropriate sample size was computed when the study was being designed  You should state the statistical method of sample size computation and any required assumptions  If no explicit power analysis was used, you should describe how you decided what sample (replicate) size (number) to use Please outline where this information can be found within the submission (e.g., sections or figure legends), or explain why this information doesn't apply to your submission:
Replicates  You should report how often each experiment was performed  You should include a definition of biological versus technical replication  The data obtained should be provided and sufficient information should be provided to indicate the number of independent biological and/or technical replicates  If you encountered any outliers, you should describe how these were handled  Criteria for exclusion/inclusion of data should be clearly stated  High-throughput sequence data should be uploaded before submission, with a private link for reviewers provided (these are available from both GEO and ArrayExpress)
Please outline where this information can be found within the submission (e.g., sections or figure legends), or explain why this information doesn't apply to your submission:
Details on sample size decision can be found in materials and methods (sections In vitro bioluminescence assays and In vivo models).
In applicable experiments, sample size can be found in the figure legends (figure 2, 4, 5 and 6).
In applicable experiments, information on replicates can be found in materials and methods (section In vitro bioluminescence assays and figure legends (figure 2)).
The synthetic chemistry was performed as written in the Supplementary Information. Each step will have been repeated 3-5 times and optimized to some extent during these. The yields quoted are of the average experiment, that is not the lowest or highest yields, but the one most often obtained. Statistical reporting  Statistical analysis methods should be described and justified  Raw data should be presented in figures whenever informative to do so (typically when N per group is less than 10)  For each experiment, you should identify the statistical tests used, exact values of N, definitions of center, methods of multiple test correction, and dispersion and precision measures (e.g., mean, median, SD, SEM, confidence intervals; and, for the major substantive results, a measure of effect size (e.g., Pearson's r, Cohen's d)  Report exact p-values wherever possible alongside the summary statistics and 95% confidence intervals. These should be reported for all key questions and not only when the p-value is less than 0.05.
(For large datasets, or papers with a very large number of statistical tests, you may upload a single table file with tests, Ns, etc., with reference to sections in the manuscript.)
Group allocation
 Indicate how samples were allocated into experimental groups (in the case of clinical studies, please specify allocation to treatment method); if randomization was used, please also state if restricted randomization was applied  Indicate if masking was used during group allocation, data collection and/or data analysis Please outline where this information can be found within the submission (e.g., sections or figure legends), or explain why this information doesn't apply to your submission:
Additional data files ("source data")  We encourage you to upload relevant additional data files, such as numerical data that are represented as a graph in a figure, or as a summary table  Where provided, these should be in the most useful format, and they can be uploaded as "Source data" files linked to a main figure or table  Include model definition files including the full list of parameters used  Include code used for data analysis (e.g., R, MatLab)  Avoid stating that data files are "available upon request" Statistical methods are outlined in the materials and methods section 'Statistical analysis'. In addition, details of specific statistical methods and values can be found in sections 'Spectral unmixing of firefly luciferase mutants in vitro', 'Spectral characterisation of firefly luciferase mutants with LH2 and iLH2 in vivo', 'Spectral unmixing of firefly luciferase mutants in vivo' and the legend of Figure  4 .
For both in vitro and in vivo experiments the same cells/mice were tested with both LH2 and iLH2, so group allocation does not apply to most of this submission. The only exception is the experiment carried out in the section 'Application of dual bioluminescence imaging using infraluciferin' where details of group allocation can be found in the legend of figure 6.
